Skip to main content
Journal cover image

Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.

Publication ,  Journal Article
Samsky, MD; Dunning, A; DeVore, AD; Schulte, PJ; Starling, RC; Tang, WHW; Armstrong, PW; Ezekowitz, JA; Butler, J; McMurray, JJ; Teerlink, JR ...
Published in: Eur J Heart Fail
April 2016

AIMS: We aimed to characterize abnormal liver function tests in patients with heart failure (HF), as they are commonly encountered yet poorly defined. METHODS AND RESULTS: We used data from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) to characterize associations with baseline liver function tests (LFTs). Each LFT was analysed as both a continuous and dichotomous variable [normal vs. abnormal; bilirubin >1.0 mg/dL; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) >35 mmol/L]. Logistic regression assessed the association of LFTs and 30-day all-cause mortality and HF rehospitalization, and Cox proportional hazards assessed the association with 180-day all-cause mortality among patients alive at a 30-day landmark. In ASCEND-HF, 4228 (59%) had complete admission LFT data. Of these, 42% had abnormal bilirubin, 22% had abnormal ALT, and 30% had abnormal AST. Patients with abnormal LFTs were younger, had lower body mass index, and lower left ventricular ejection fraction. In multivariable models, increased total bilirubin was associated with increased 30-day mortality or HF rehospitalization [hazard ratio (HR) 1.17 per 1 mg/dL increase, 95% confidence interval (CI) 1.04, 1.32; P = 0.012], but not with an increase in 180-day mortality (HR 1.10, 95% CI 0.97, 1.25; P = 0.13) per 1 mg/dl increase. Compared with normal bilirubin levels, abnormal bilirubin was associated with increased 30-day mortality or HF rehospitalization (HR 1.24, 95% CI 1.00, 1.54; P = 0.048) and 180-day mortality (HR 1.32, 95% CI 1.08, 1.62; P = 0.007). We found no association with AST or ALT and outcomes. CONCLUSION: Greater than 40% of patients hospitalized with acute HF had abnormal LFTs. After multivariable adjustment, only elevated bilirubin was independently associated with worse clinical outcomes and may represent an important prognostic variable.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur J Heart Fail

DOI

EISSN

1879-0844

Publication Date

April 2016

Volume

18

Issue

4

Start / End Page

424 / 432

Location

England

Related Subject Headings

  • Stroke Volume
  • Proportional Hazards Models
  • Prognosis
  • Patient Readmission
  • Multivariate Analysis
  • Mortality
  • Middle Aged
  • Male
  • Logistic Models
  • Liver Function Tests
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Samsky, M. D., Dunning, A., DeVore, A. D., Schulte, P. J., Starling, R. C., Tang, W. H. W., … Hernandez, A. F. (2016). Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. Eur J Heart Fail, 18(4), 424–432. https://doi.org/10.1002/ejhf.440
Samsky, Marc D., Allison Dunning, Adam D. DeVore, Phillip J. Schulte, Randall C. Starling, WH Wilson Tang, Paul W. Armstrong, et al. “Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.Eur J Heart Fail 18, no. 4 (April 2016): 424–32. https://doi.org/10.1002/ejhf.440.
Samsky MD, Dunning A, DeVore AD, Schulte PJ, Starling RC, Tang WHW, et al. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. Eur J Heart Fail. 2016 Apr;18(4):424–32.
Samsky, Marc D., et al. “Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.Eur J Heart Fail, vol. 18, no. 4, Apr. 2016, pp. 424–32. Pubmed, doi:10.1002/ejhf.440.
Samsky MD, Dunning A, DeVore AD, Schulte PJ, Starling RC, Tang WHW, Armstrong PW, Ezekowitz JA, Butler J, McMurray JJ, Teerlink JR, Voors AA, Metra M, Mentz RJ, O’Connor CM, Patel CB, Hernandez AF. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. Eur J Heart Fail. 2016 Apr;18(4):424–432.
Journal cover image

Published In

Eur J Heart Fail

DOI

EISSN

1879-0844

Publication Date

April 2016

Volume

18

Issue

4

Start / End Page

424 / 432

Location

England

Related Subject Headings

  • Stroke Volume
  • Proportional Hazards Models
  • Prognosis
  • Patient Readmission
  • Multivariate Analysis
  • Mortality
  • Middle Aged
  • Male
  • Logistic Models
  • Liver Function Tests